| 2D Structure | |
| CID | 8246 |
| IUPAC Name | [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium bromide |
| InChI | InChI=1S/C12H19N2O2.BrH/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;/h6-9H,1-5H3;1H/q+1;/p-1 |
| InChI Key | LULNWZDBKTWDGK-UHFFFAOYSA-M |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C12H19BrN2O2 |
| Molecular Weight | 303.20 |
| synonyms | ['neostigmine bromide', '114-80-7', 'Vagostigmin', 'Kirkstigmine bromide', 'Eustigmin bromide', 'Neoserine bromide', 'Syntostigmin bromide', 'neo-Proserin', 'Proserine bromide', 'Stigmanol bromide', 'Synstigmin bromide', 'Leostigmine bromide', 'Neostigmini bromidum', 'Philostigmin bromide', 'Neo proserine', 'Bromure de neostigmine', 'Bromuro de neostigmina', 'Neostigmine methyl bromide', 'Neoproserine', '(m-Hydroxyphenyl)trimethylammonium bromide dimethylcarbamate', 'NSC-757233', '3-Dimethylcarbamoxyphenyl trimethyl ammonium bromide', 'DTXSID9041075', '005SYP50G5', '3-Hydroxyphenyltrimethylammonium bromide dimethylcarbamic ester', 'DTXCID7021075', 'CHEBI:179557', 'Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, bromide', '[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;bromide', 'Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide', '(3-(dimethylcarbamoyloxy)phenyl)-trimethylazanium;bromide', 'Bromide, Neostigmine', 'RefChem:832351', '204-054-8', '3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide', 'MFCD00011795', '3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium bromide', 'Neostigmine (Bromide)', 'MLS000028387', 'SMR000058591', 'Stigmosan bromide', 'Prostigmin bromide', 'Prostigmine bromide', 'Synstigmini bromidum', 'Vagostigmine bromide', 'Syntostigmine bromide', '3-(Dimethylcarbamoyloxy)trimethylanilinium ion Bromatum', 'Synthostigmine bromide', 'Syntostigmin (tablet)', 'Synstigminbromid', 'Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide (1:1)', 'Neostigmina bromuro', 'Neostigmina bromuro [DCIT]', 'Neostigmini bromidum [INN-Latin]', 'NEOSTIGMINEBROMIDE', 'SR-01000000073', 'NCGC00163240-01', 'CAS-114-80-7', 'EINECS 204-054-8', 'Bromure de neostigmine [INN-French]', 'Bromuro de neostigmina [INN-Spanish]', 'Neoesserin', '114-80-7 (bromide)', 'UNII-005SYP50G5', 'Eustigmin bromide;Neoserine bromide', 'Vagostigmin (TN)', 'Prestwick_352', 'Neostigmine bromide [USP:INN:BAN:JAN]', 'Neostigmine bromide CRS', 'Opera_ID_1504', 'Carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium bromide', 'NEO PROSERINE [JAN]', 'SCHEMBL41128', 'MLS001146913', 'orb342006', 'CHEMBL54126', 'SPECTRUM1500428', 'LCZC2572', 'orb2946024', 'Neostigmine bromide (Prostigmin)', 'NEOSTIGMINE BROMIDE [MI]', 'SCHEMBL29618009', 'HMS500I07', 'HY-B0423R', 'NEOSTIGMINE BROMIDE [INN]', 'NEOSTIGMINE BROMIDE [JAN]', 'LULNWZDBKTWDGK-UHFFFAOYSA-M', 'Neostigmine (Bromide) (Standard)', 'HMS1569M18', 'HMS1920P15', 'HMS2091H18', 'HMS2096M18', 'HMS2235J11', 'HMS3262D13', 'HMS3372E02', 'HMS3713M18', 'Pharmakon1600-01500428', 'NEOSTIGMINE BROMIDE [VANDF]', 'HY-B0423', 'MSK10462', 'NEOSTIGMINE BROMIDE [MART.]', 'Neostigmine bromide (JAN/USP/INN)', 'Tox21_112037', 'Tox21_500816', 'CCG-39110', 'EBC-04137', 'NEOSTIGMINE BROMIDE [USP-RS]', 'NEOSTIGMINE BROMIDE [WHO-DD]', 'NEOSTIGMINE BROMIDE [WHO-IP]', 'NSC757233', 's2490', 'AKOS015895725', 'AMMONIUM, (m-HYDROXYPHENYL)TRIMETHYL-, BROMIDE, DIMETHYLCARBAMATE', 'Tox21_112037_1', 'FN26183', 'LP00816', 'NSC 757233', 'NCGC00015730-11', 'NCGC00094149-01', 'NCGC00094149-02', 'NCGC00094149-03', 'NCGC00094149-04', 'NCGC00261501-01', 'BS-14646', 'DA-66031', 'NEOSTIGMINE BROMIDE [EP MONOGRAPH]', 'MLS-0002855.P042', 'NEOSTIGMINE BROMIDE [USP MONOGRAPH]', 'NEOSTIGMINI BROMIDUM [WHO-IP LATIN]', 'EU-0100816', 'N0358', 'NS00079222', 'ST50411544', 'C08197', 'C71473', 'D00995', 'N 2001', 'EN300-12576352', 'F160100', 'SR-01000000073-3', 'SR-01000000073-5', 'SR-01000000073-7', '(3-Dimethylcarbamoyloxyphenyl)trimethylammonium Bromide', 'Q27105147', '[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium;bromide', 'N,N-dimethyl[3-(trimethylamino)phenoxy]carboxamide, bromide', 'Neostigmine bromide, >=98% (HPLC and titration), powder', '(3-Hydroxyphenyl)trimethylammonium Bromide Dimethyl Carbamate', '3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium bromide', 'Neostigmine bromide, European Pharmacopoeia (EP) Reference Standard', 'Neostigmine bromide, United States Pharmacopeia (USP) Reference Standard'] |
From Pubchem